中国乳腺癌筛查与早期诊断指南  

Screening and early diagnosis of breast cancer in China:a practice guideline

作　　者：中国抗癌协会乳腺癌专业委员会 吴炅[2] The Society of Breast Cancer,China Anti-Cancer Association

机构地区：[1]不详 [2]复旦大学附属肿瘤医院

出　　处：《中国癌症杂志》2022年第4期363-372,共10页China Oncology

基　　金：中国老年保健协会提供了本项目资金

摘　　要：中国抗癌协会乳腺癌专业委员会于2020年4月—2021年11月,采用改编《欧盟委员会乳腺癌指南》的方法,编写制定了《中国乳腺癌筛查和早期诊断指南》(后文简称指南)。指南遵循GRADE系统方法,共包括50条推荐意见和5条专家共识,涉及乳腺癌的筛查、早期诊断、复发风险基因检测以及筛查项目中的沟通和培训等专业领域。指南推荐意见的形成考虑了目前最佳循证医学证据、中国女性群体的价值观念与偏好、成本和资源配置等因素。在应用本指南推荐的筛查和诊断技术时,应结合各地实际情况。Between April 2020 and November 2021,the Chinese Breast Cancer Society developed practice guideline on screening and early diagnosis of breast cancer in China,which adapted from European Commission Initiative on Breast Cancer with GRADE approach.This practice guideline includes 50 recommendations and 5 expert consensus statements,with a scope of screening,early diagnosis,genetic testing on recurrence risk,and communication and training in the screening program.The formulation of recommendations considered best available evidence-based medicine,sense of worth and preferences of Chinese women,and cost and resource utilization.The implementation of recommended screening and diagnostic strategies need to consider the local contexts.

关 键 词：乳腺癌 筛查 早期诊断 指南 

分 类 号：R737.9[医药卫生—肿瘤]